Sho1 Inhibitors
Chemical inhibitors of Sho1 can exert their inhibitory effects through various mechanisms by targeting specific proteins and enzymes that are part of the signaling pathways Sho1 is involved in. Staurosporine is a broad-spectrum protein kinase inhibitor that can inhibit the function of Sho1 by preventing essential phosphorylation events necessary for its signaling function, including the phosphorylation of Sho1 itself or of crucial proteins upstream. Similarly, genistein's role as a tyrosine kinase inhibitor means that it can halt tyrosine phosphorylation processes that are potentially important for Sho1's activity. LY294002 and Wortmannin, both phosphatidylinositol 3-kinase (PI3K) inhibitors, can impede the PI3K pathway, thus disrupting the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 is a critical secondary messenger in numerous signaling pathways, and its absence can prevent the activation of downstream kinases that may be required for the proper signaling through Sho1.
In addition, U0126 and PD98059 are inhibitors of MEK1/2, which act upstream of the ERK/MAPK pathway. By inhibiting MEK, these chemicals prevent the activation of ERK, which could be a necessary step for Sho1 signaling. SB203580's inhibition of p38 MAPK and SP600125's inhibition of JNK can similarly disrupt MAPK pathway signaling, which may be crucial for the function of Sho1. PP2 and Dasatinib, both Src family tyrosine kinase inhibitors, as well as Imatinib, which targets BCR-ABL, c-KIT, and PDGFR, can block critical tyrosine kinase-dependent steps that Sho1 may rely on. Lastly, Sorafenib's inhibition of Raf kinase can disrupt signaling cascades downstream of Raf, which can include pathways involving Sho1. Each of these chemicals can act on specific enzymes or kinases within the cellular signaling pathways, leading to the functional inhibition of Sho1 by halting the necessary activation signals that it requires to carry out its role in the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Since Sho1 is involved in a signaling pathway that requires phosphorylation events, staurosporine could inhibit the function of Sho1 by preventing its phosphorylation or the phosphorylation of proteins upstream that are required for Sho1's proper signaling function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. If Sho1 signaling requires tyrosine phosphorylation directly or in upstream signaling components, genistein could inhibit these phosphorylation events, thereby inhibiting Sho1 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor. If the Sho1 signaling pathway involves PI3K activity, inhibiting PI3K would disrupt the production of PIP3, which is crucial for full activation of AGC family kinases, potentially inhibiting Sho1 signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. By inhibiting PI3K, Wortmannin can prevent activation of downstream targets that may be required for Sho1 signaling, resulting in functional inhibition of Sho1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway. If Sho1 utilizes the MAPK pathway for signaling, inhibiting MEK could prevent activation of ERK, thus inhibiting the signaling cascade that involves Sho1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that prevents the activation of MAPK/ERK. As with U0126, by inhibiting MEK, PD98059 can prevent downstream signaling that might involve Sho1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. If Sho1's function is connected to the p38 MAPK pathway, inhibiting p38 MAPK could disrupt the signaling cascade and inhibit Sho1 function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK. If Sho1 is involved in a signaling pathway that includes JNK, inhibiting JNK would prevent downstream signaling and inhibit Sho1 function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a Src family tyrosine kinase inhibitor. If the signaling involving Sho1 requires Src kinase activity, PP2 could inhibit this activity, thus inhibiting Sho1 function. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a multi-kinase inhibitor with activity against Src family kinases and c-KIT. If Sho1 signaling is dependent on these kinases, dasatinib could inhibit their activity and consequently inhibit the function of Sho1. | ||||||